Recent Progress in the Discovery of New CCR5 and CXCR4 Chemokine Receptor Antagonists as Inhibitors of HIV-1 Entry. Part 2*

Publisher： Bentham Science Publishers

E-ISSN： 1875-600x|4|2|133-152

ISSN： 1568-0126

Source： Current Medicinal Chemistry - Anti-Infective Agents, Vol.4, Iss.2, 2005-04, pp. : 133-152

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent Progress in Small Molecule CCR5 Antagonists as Potential HIV-1 Entry Inhibitors

By  

Current Pharmaceutical Design, Vol. 18, Iss. 1, 2012-01 ,pp. : 100-112

Bentham Science Publishers

Access to resources Recommend Favorite

Small-Molecule Antagonists of CCR5 and CXCR4: A Promising New Class of Anti-HIV-1 Drugs

By  

Current Pharmaceutical Design, Vol. 10, Iss. 17, 2004-07 ,pp. : 2041-2062

Bentham Science Publishers

Access to resources Recommend Favorite

Chemokine receptor antagonists as HIV entry inhibitors

By  

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 2, 2004-02 ,pp. : 251-255

Informa Healthcare

Access to resources Recommend Favorite

Recent progress in the development of antagonists to the chemokine receptors CCR3 and CCR4

By Pease James Edward   Horuk Richard  

Expert Opinion on Drug Discovery, Vol. 9, Iss. 5, 2014-05 ,pp. : 467-483

Informa Healthcare

Access to resources Recommend Favorite

Small Molecule Antagonists of the Chemokine Receptor CCR5

By  

Current Topics in Medicinal Chemistry, Vol. 10, Iss. 13, 2010-09 ,pp. : 1299-1338

Bentham Science Publishers

Access to resources Recommend Favorite